Coronary Artery Disease Studies

AEGIS II Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group - Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome
Principal Investigator: Nabil Dib, MD

https://clinicaltrials.gov/ct2/show/NCT03473223?term=AEGIS+II&draw=2&rank=1

For questions, please call 480-728-9979.

ECLIPSE - Evaluation of Treatment Strategies for Severe Calcific Coronary Arteries: Orbital Artheretomy vs Conventional Angioplasty Technique Prior to Implantation of Drug-Eluding Stents
Principal Investigator: Georges Nseir, MD 

https://clinicaltrials.gov/ct2/show/NCT03108456?term=ECLIPSE&draw=2&rank=2

For questions, please call 480-728-9979.

SAFE-STEMI for Seniors - Study of Access Site for Enhancing PCI in STEMI for Seniors
Principal Investigator: Nabil Dib, MD

https://clinicaltrials.gov/ct2/show/NCT02939976?term=SAFE+STEMI&draw=2&rank=1

For questions, please call 480-728-9979.

WARRIOR – Women’s Ischemia Trial to Reduce Events in Non-Obstructive CAD 
Principal Investigator: Rachel Bond, MD

https://clinicaltrials.gov/ct2/show/NCT03417388?term=WARRIOR&draw=2&rank=1

For questions, please call 480-728-9979.

EMPACT- MI – A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack
Principal Investigator: Nabil Dib, MD

https://clinicaltrials.gov/ct2/show/NCT04509674?term=EMPACT&draw=2&rank=2

For questions, please call 480-728-9979.

TARGET IV - Multicenter Randomized Assessment of the FirehawkTM rapamycin TARGET eluting cobalt chromium coronary stent system(Firehawk™ stent system)
Principal Investigator: Nabil Dib, MD

https://clinicaltrials.gov/ct2/show/NCT04562532?term=TARGET+IV&draw=2&rank=1

For questions, please call 480-728-9979.

RESTOR-COR-1 Early Feasibility Study
Early Feasibility Study of the Angiosafe Coronary CTO (Chronic Total Occlusion) Crossing System
Principal Investigator: Ashish Pershad, MD

For questions call: 480-728-9979

VICTORION-2P - Cardiovascular Events Prevention
Study of Inclisiran to Prevent Cardiovascular Events in Participants with Established Cardiovascular Disease.
Principal Investigator: Nabil Dib, MD

https://clinicaltrials.gov/ct2/show/NCT05030428?term=VICTORION&draw=2&rank=2

For questions call: 480-728-9979

SOS-AMI Selatogrel Outcome Study in Suspected Acute Myocardial Infarction
This study will assess the clinical efficacy of Selatogrel when administered upon occurrence of symptoms suggestive of an acute myocardial infarction (AMI) in participants at risk of having a recurrent AMI.
Principal Investigator: Nabil Dib, MD

https://clinicaltrials.gov/ct2/show/NCT04957719?term=SOS-AMI&draw=2&rank=1

For questions call: 480-728-9979

EVOLVE- MI Evolocumab Very Early After Myocardial Infaction
Study to evaluate the effectiveness of early treatment with evolocumab plus routine lipid management vs routine lipid management alone in reducing MI, stroke, revascularization and all-case death in subjects hospitalized with acute MI. 
Principal Investigator: Nabil Dib, MD

https://clinicaltrials.gov/ct2/show/NCT05284747?term=EVOLVE+MI&draw=2&rank=1

For questions call: 480-728-9979

Research Studies Home

See other studies for:

Cardiovascular

Arrhythmia

Cardiac Genomics

Coronary Artery Disease

Heart Failure

Structural Heart

Additional studies

Brain Tumors - Neuro Oncology

COVID-19

Infectious Disease

Peripheral Artery Disease

Point of Care

Stroke

Trauma